|
Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 122.08 CHF | +0.44% |
|
+3.48% | +11.39% |
| 12.06. | Aktien Schweiz Schluss: Hoffnungen im Iran-Krieg und SpaceX treiben | AW |
| 12.06. | Novartis: Rhapsido erreicht primäre Endpunkte in Studie zu chronisch induzierbarer Urtikaria | MT |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | % 1 Jahr | Veränd. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.44% | +3.48% | +4.52% | +0.59% | +11.39% | +25.65% | +35.66% | +46.52% | +62.56% | 281 Mrd. | |
| -2.41% | +0.14% | +11.54% | +15.02% | +5.43% | +38.28% | +154.20% | +405.60% | +1’433.98% | 1’010 Mrd. | |
| +1.07% | +3.48% | +4.54% | -0.27% | +16.39% | +53.32% | +49.85% | +46.02% | +106.24% | 580 Mrd. | |
| +1.32% | +0.22% | +9.22% | +3.66% | -0.33% | +19.18% | +64.65% | +97.31% | +279.99% | 402 Mrd. | |
| +0.77% | 0.00% | +2.22% | +2.00% | -0.34% | +21.28% | +16.70% | -4.36% | +33.24% | 330 Mrd. | |
| -0.85% | -2.86% | -2.21% | -6.38% | -2.38% | +22.54% | +14.67% | +61.41% | +251.95% | 280 Mrd. | |
| +1.66% | +1.20% | -3.99% | +16.27% | -11.68% | -44.35% | -47.35% | +11.16% | +58.18% | 197 Mrd. | |
| +0.32% | +1.61% | +5.57% | -3.01% | +8.52% | +20.32% | +60.01% | +46.31% | +132.04% | 192 Mrd. | |
| -0.22% | -2.76% | -5.61% | -13.38% | +2.32% | +14.19% | +60.09% | +82.62% | +49.55% | 156 Mrd. | |
| +0.15% | +0.65% | +0.96% | -1.39% | +5.26% | +6.81% | -34.93% | -34.72% | -24.55% | 149 Mrd. | |
| +0.40% | -0.24% | +1.31% | -3.30% | +5.91% | +14.83% | -11.78% | -15.16% | -20.89% | 117 Mrd. | |
| -0.03% | -0.43% | -1.80% | -5.20% | -1.86% | -2.31% | +30.06% | +130.51% | +391.41% | 113 Mrd. | |
| +0.38% | -1.74% | +5.32% | +0.26% | -7.41% | -11.76% | -18.46% | -13.85% | +10.22% | 106 Mrd. | |
| +1.10% | +2.37% | +5.20% | -2.31% | +8.74% | +31.26% | +45.18% | +13.10% | +12.09% | 106 Mrd. | |
| +0.30% | -1.38% | -4.55% | -20.42% | -9.62% | -0.09% | +79.39% | +70.17% | +500.81% | 76.54 Mrd. | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66 Mrd. | |
| +0.97% | +3.17% | -2.12% | -10.42% | +5.11% | +16.85% | +12.33% | +34.48% | +14.23% | 50.12 Mrd. | |
| +3.21% | +2.99% | -13.19% | -12.01% | -18.60% | -10.02% | +7.76% | -33.54% | +240.33% | 47.41 Mrd. | |
| +1.12% | +0.08% | -4.69% | -6.33% | -2.22% | +31.70% | -29.43% | -32.32% | -58.90% | 41.16 Mrd. | |
| +0.20% | +1.29% | -4.47% | +21.21% | +10.96% | +103.83% | +359.89% | +211.70% | -34.93% | 40.32 Mrd. | |
| Durchschnitt | +0.49% | +0.93% | +0.41% | -1.34% | +1.35% | +18.50% | +44.66% | +59.10% | +180.92% | 216.99 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | -0.07% | +0.95% | +4.34% | +2.95% | +4.06% | +24.70% | +61.24% | +128.35% | +433.52% |
- Börse
- Aktien
- 904278 Aktie
- Sektor Novartis AG
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben